Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31123134.
- Also identified by DOI 10.1126/science.aav6390.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug-resistance dissemination by horizontal gene transfer remains poorly understood at the cellular scale. Using live-cell microscopy, we reveal the dynamics of resistance acquisition by transfer of the <i>Escherichia coli</i> fertility factor-conjugation plasmid encoding the tetracycline-efflux pump TetA. The entry of the single-stranded DNA plasmid into the recipient cell is rapidly followed by complementary-strand synthesis, plasmid-gene expression, and production of TetA. In the presence of translation-inhibiting antibiotics, resistance acquisition depends on the AcrAB-TolC multidrug efflux pump, because it reduces tetracycline concentrations in the cell. Protein synthesis can thus persist and TetA expression can be initiated immediately after plasmid acquisition. AcrAB-TolC efflux activity can also preserve resistance acquisition by plasmid transfer in the presence of antibiotics with other modes of action.
Medical subject headings
- Carrier Proteins
- Drug Resistance, Multiple, Bacterial
- Escherichia coli
- Escherichia coli Proteins
- F Factor